Prolonged Survival of Murine Fibrosarcoma Allotransplants by Anti-Enhancing Fab Alloantibody
Immunological Communications · 1972
DOI: 10.3109/08820137209022949 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunological Communications, 1972. Verfasst von J M Cruse und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Antibodies, Anti-Idiotypic, Neoplasm Transplantation, Transplantation Immunology, Transplantation, Homologous. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 14 Literaturangaben.
Abstract (Originalsprache)
Anti-alloantibody whole molecules and subunits have been shown to inhibit specific recognition of foreign antigenic determinants by certain thymus-dependent lymphoid cells. The present investigation was designed to demonstrate whether anti-Fab and anti-Fc alloantibodies raised against Fab and Fc fragments prepared by papain digestion of tumor-enhancing IgG2 could prolong the survival of C3Hf/He (H-2k) fibrosarcoma allografts in TS (H-2s) mice. Prolonged survival of tumor allografts was observed in TS mice that received anti-Fab alloantibody followed one hour later by tumor allotransplantation, whereas anti-Fc alloantibody showed no such effect when assayed under similar conditions. By contrast, no significant difference in allograft survival time was observed between TS mice that received anti-Fc alloantibody and control mice that received 0.15 M NaCl each followed within one hour by tumor allotransplantation. The injection of γ -globulin fraction of alloantisera absorbed with enhancing Fab fragments covalently linked to an insoluble matrix led to tumor allograft rejection complete by 14 days post inoculation. Results of this study are consistent with the concept that immunoglobulin-like molecules act as T-lymphoid cellular receptors in allograft rejection (i.e., a thymus dependent process).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Cruse, J. M., Lewis, G. K., Whitten, H. D., Watson, E. S., Hester, R. B., & Fields, J. F. (1972). Prolonged Survival of Murine Fibrosarcoma Allotransplants by Anti-Enhancing Fab Alloantibody. Immunological Communications. https://doi.org/10.3109/08820137209022949
Vancouver
Cruse JM, Lewis GK, Whitten HD, Watson ES, Hester RB, Fields JF. Prolonged Survival of Murine Fibrosarcoma Allotransplants by Anti-Enhancing Fab Alloantibody. Immunological Communications. 1972. doi:10.3109/08820137209022949
BibTeX
@article{Cruse1972,
author = {Cruse, J M and Lewis, G K and Whitten, H D and Watson, E S and Hester, R B and Fields, J F},
title = {Prolonged Survival of Murine Fibrosarcoma Allotransplants by Anti-Enhancing Fab Alloantibody},
journal = {Immunological Communications},
year = {1972},
doi = {10.3109/08820137209022949}
}
EUVIMED